- Home
- SNGX vs LMFA Comparison
SNGX vs LMFA Comparison
Compare SNGX & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- LMFA
- Stock Information
- Founded
- SNGX 1987
- LMFA 2008
- Country
- SNGX United States
- LMFA United States
- Employees
- SNGX N/A
- LMFA N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- LMFA Finance: Consumer Services
- Sector
- SNGX Health Care
- LMFA Finance
- Exchange
- SNGX Nasdaq
- LMFA Nasdaq
- Market Cap
- SNGX 10.1M
- LMFA 11.9M
- IPO Year
- SNGX 1987
- LMFA 2015
- Fundamental
- Price
- SNGX $2.86
- LMFA $1.09
- Analyst Decision
- SNGX Strong Buy
- LMFA Strong Buy
- Analyst Count
- SNGX 1
- LMFA 1
- Target Price
- SNGX $6.00
- LMFA $5.00
- AVG Volume (30 Days)
- SNGX 10.2M
- LMFA 613.3K
- Earning Date
- SNGX 11-07-2025
- LMFA 08-14-2025
- Dividend Yield
- SNGX N/A
- LMFA N/A
- EPS Growth
- SNGX N/A
- LMFA N/A
- EPS
- SNGX N/A
- LMFA N/A
- Revenue
- SNGX N/A
- LMFA $6,755,925.00
- Revenue This Year
- SNGX N/A
- LMFA N/A
- Revenue Next Year
- SNGX N/A
- LMFA $6.50
- P/E Ratio
- SNGX N/A
- LMFA N/A
- Revenue Growth
- SNGX N/A
- LMFA N/A
- 52 Week Low
- SNGX $1.09
- LMFA $1.02
- 52 Week High
- SNGX $6.23
- LMFA $5.14
- Technical
- Relative Strength Index (RSI)
- SNGX 49.77
- LMFA 32.62
- Support Level
- SNGX $2.72
- LMFA $1.04
- Resistance Level
- SNGX $3.11
- LMFA $1.34
- Average True Range (ATR)
- SNGX 0.49
- LMFA 0.12
- MACD
- SNGX -0.10
- LMFA -0.03
- Stochastic Oscillator
- SNGX 3.99
- LMFA 3.78
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.